Skip to main content
Premium Trial:

Request an Annual Quote

Bernard Reculeau, Jeff Whitmore, Andre Marion

Premium
Cisbio this week announced that Bernard Reculeau has been appointed CEO.
 
Prior to joining Cisbio, Reculeau was managing director of Sanofi-Aventis International. He is a graduate of France’s National School of Administration and the Institute of Political Studies in Paris.
 

 
Alpha Innotech this week said that Jeff Whitmore has joined the company as vice president of global sales.
 
Whitmore most recently served as director of European life sciences sales for Molecular Devices in London. Prior to this, Whitmore held various sales positions for Molecular Devices and Bio-Rad Laboratories. He holds a BS in microbiology from the University of Wisconsin.
 

 
Singulex this week said that it has appointed Andre Marion to its board of directors.
 
Marion is the founder of Applied Biosystems, and served as its CEO from 1986 to 1993; and chairman of the board from 1987 to 1993, when it merged with Perkin-Elmer. Presently, Marion is a management consultant and director of several biotechnology companies, including Molecular Devices, Applied Imaging, Alpha MOS, and Guava Technologies.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.